Specimen Collection for COVID-19 Testing – Payment Updates

Under the recently released Interim Final Rule from the Centers for Medicare and Medicaid Services (CMS), payment rules for specimen collection are changing for the public health emergency (PHE) caused by the COVID-19 pandemic. With this change, CMS will provide payment to independent laboratories, under certain circumstances, for specimen collection from home-bound beneficiaries or inpatients not in a hospital to be tested for COVID-19. Additionally, two new Level II HCPCS codes have been released to report specimen collection for COVID-19 testing.

G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]),